STM 002
Alternative Names: STM-002Latest Information Update: 01 Apr 2021
At a glance
- Originator SuperTrans Medical
- Class Anti-inflammatories; Antibacterials; Drug conjugates
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Intra-abdominal infections; Pneumonia; Urinary tract infections
Most Recent Events
- 30 Mar 2021 Preclinical trials in Intra-abdominal infections in Australia (IV) prior to March 2021 (SuperTrans Medical pipeline, March 2021)
- 30 Mar 2021 Preclinical trials in Pneumonia in Australia (IV) prior to March 2021 (SuperTrans Medical pipeline, March 2021)
- 30 Mar 2021 Preclinical trials in Urinary tract infections in Australia (IV) prior to March 2021 (SuperTrans Medical pipeline, March 2021)